Smith & Nephew SNATS - 20 Year Stock Price History | SNN

Historical daily share price chart and data for Smith & Nephew SNATS since 1999 adjusted for splits. The latest closing stock price for Smith & Nephew SNATS as of April 24, 2019 is 38.29.
  • The all-time high Smith & Nephew SNATS stock price is 40.46, which is 5.7% above the current share price.
  • The Smith & Nephew SNATS 52-week high stock price is 40.46, which is 5.7% above the current share price.
  • The Smith & Nephew SNATS 52-week low stock price is 32.40, which is 15.4% below the current share price.
  • The average Smith & Nephew SNATS stock price for the last 52 weeks is 36.83.
Smith & Nephew SNATS Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 38.6141 36.4000 40.4600 35.5100 38.2900 2.43%
2018 36.0218 34.2179 39.1370 32.4000 37.3800 8.90%
2017 33.1929 28.8624 37.7475 28.7758 34.3257 18.57%
2016 30.8841 32.8692 33.4878 26.0907 28.9490 -13.91%
2015 32.7978 33.3647 35.4415 30.6779 33.6248 -1.39%
2014 30.2808 25.8154 35.8583 25.8154 34.0979 30.43%
2013 21.6627 19.8568 26.1835 18.8484 26.1434 32.44%
2012 17.8999 17.0745 19.8318 15.9151 19.7392 17.38%
2011 17.7977 18.0890 20.6991 14.6251 16.8161 -6.95%
2010 16.3195 17.4964 18.2793 14.1065 18.0718 4.05%
2009 13.3508 10.8519 17.4117 10.1761 17.3677 61.53%
2008 17.9182 18.9682 22.5689 10.1162 10.7520 -43.11%
2007 19.7558 17.0814 22.3056 16.9835 18.8991 10.73%
2006 14.4510 15.2752 17.1727 11.9982 17.0683 14.17%
2005 15.3933 16.2227 16.8657 12.9852 14.9495 -9.50%
2004 15.6059 13.2311 18.4355 12.9022 16.5195 24.62%
2003 10.4015 9.6648 13.3765 8.3743 13.2564 38.19%
2002 9.0059 9.3110 9.9395 7.5273 9.5929 2.18%
2001 7.6490 7.0033 9.4036 6.3715 9.3882 33.71%
2000 5.9753 6.1129 7.0215 4.6477 7.0215 14.63%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $16.746B $4.904B
Smith & Nephew is a global medical device company. The company markets clinically superior products, principally in orthopaedics, endoscopy and wound management to deliver cost-effective solutions, significant physicianadvantage and real patient benefits. A continuous process of supplying new and innovative products is supported by substantial R&D investment todeliver new levels of healing to patients throughout the world
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $134.809B 26.28
Medtronic (MDT) Ireland $114.856B 16.79
Stryker (SYK) United States $69.039B 24.64
Boston Scientific (BSX) United States $49.279B 23.63
Baxter (BAX) United States $38.988B 25.01
Zimmer Biomet Holdings (ZBH) United States $25.460B 16.29
Canopy Growth (CGC) Canada $16.646B 0.00
ResMed (RMD) United States $14.578B 27.64
Aurora Cannabis (ACB) Canada $9.230B 65.07
Bio-Rad Laboratories (BIO) United States $8.754B 50.22
Perrigo (PRGO) Ireland $6.685B 10.84
Hill-Rom Holdings (HRC) United States $6.417B 19.85
Insulet (PODD) United States $4.971B 1666.40
GW Pharmaceuticals (GWPH) United Kingdom $4.857B 0.00
ICU Medical (ICUI) United States $4.694B 29.07
Haemonetics (HAE) United States $4.319B 38.31
Hutchison China MediTech (HCM) China $3.951B 0.00
Agios Pharmaceuticals (AGIO) United States $3.335B 0.00
NuVasive (NUVA) United States $3.048B 26.48
Neogen (NEOG) United States $3.014B 49.01
Quidel (QDEL) United States $2.477B 22.16
National Vision Holdings (EYE) United States $2.284B 44.94
Aphria (APHA) $1.955B 0.00
HEXO (HEXO) $1.502B 0.00
Phibro Animal Health (PAHC) United States $1.342B 19.28
VAREX IMAGING (VREX) United States $1.234B 24.16
Cardiovascular Systems (CSII) United States $1.222B 877.50
AtriCure (ATRC) United States $1.081B 0.00
Lantheus Holdings (LNTH) United States $0.962B 26.00
Omeros (OMER) United States $0.930B 0.00
PetIQ (PETQ) United States $0.874B 25.02
Cerus (CERS) United States $0.826B 0.00
MacroGenics (MGNX) United States $0.805B 0.00
NanoString Technologies (NSTG) United States $0.759B 0.00
Evolus (EOLS) United States $0.721B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.720B 24.51
TG Therapeutics (TGTX) United States $0.706B 0.00
OraSure Technologies (OSUR) United States $0.596B 25.95
Surmodics (SRDX) United States $0.585B 85.02
LeMaitre Vascular (LMAT) United States $0.554B 26.32
Meridian Bioscience (VIVO) United States $0.551B 16.42
Quanterix (QTRX) United States $0.500B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.344B 0.00
Insys Therapeutics (INSY) United States $0.321B 0.00
Utah Medical Products (UTMD) United States $0.319B 20.75
BioLife Solutions (BLFS) United States $0.308B 127.08
Vapotherm (VAPO) United States $0.283B 0.00
Rockwell Medical (RMTI) United States $0.263B 0.00
Cytosorbents (CTSO) United States $0.223B 0.00
Owens & Minor (OMI) United States $0.214B 2.93
Zynex (ZYXI) United States $0.175B 18.69
Bovie Medical (APYX) United States $0.149B 0.00
Chimerix (CMRX) United States $0.129B 0.00
Fonar (FONR) United States $0.128B 6.85
Chembio Diagnostics (CEMI) United States $0.123B 0.00
Surface Oncology (SURF) United States $0.112B 0.00
United-Guardian (UG) United States $0.088B 20.27
Female Health (VERU) United States $0.086B 0.00
InfuSystems Holdings (INFU) United States $0.083B 0.00
Neurotrope (NTRP) United States $0.076B 0.00
Trinity Biotech (TRIB) Ireland $0.067B 19.86
Oramed Pharmaceuticals (ORMP) United States $0.066B 0.00
GUARDION HEALTH (GHSI) United States $0.049B 0.00
ImmuCell (ICCC) United States $0.044B 0.00
Senestech (SNES) United States $0.035B 0.00
Valeritas Holdings (VLRX) United States $0.030B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.025B 0.00
Myomo (MYO) United States $0.021B 0.00
Capricor Therapeutics (CAPR) United States $0.017B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.014B 0.00
Cellectar Biosciences (CLRB) United States $0.013B 0.00
Akers Biosciences Inc (AKER) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.007B 12.64